Clinical Trial Update: Artificial Intelligence Enhanced Optical Coherence Tomography (AI-OCT) Imaging for Pre-surgical Margin Detection of Basal Cell Carcinoma

View source ↗

Summary

A clinical trial studying AI-enhanced Optical Coherence Tomography for pre-surgical margin detection in basal cell carcinoma is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Snippet

Sponsor: Henry Ford Health System | Conditions: Basal Cell Carcinoma of Skin | Status: NOT_YET_RECRUITING